Literature DB >> 10751251

Open-ring imaging sign: highly specific for atypical brain demyelination.

J C Masdeu1, C Quinto, C Olivera, M Tenner, D Leslie, P Visintainer.   

Abstract

OBJECTIVE: To test the specificity for demyelination of a new neuroimaging sign: contrast enhancement shaped as an open ring or a crescent circumscribed to the white matter.
BACKGROUND: Brain demyelination can cause ring enhancement mimicking neoplasm or infection on CT or MRI.
METHODS: A MEDLINE search of pathology-proved demyelination yielded 32 illustrated cases of ring-enhancing lesions published between 1981 and 1995. Controls consisted of the same number of published images of neoplasms and infections, pathology proved, and matched by year of publication, and age and gender of the patient. Two neuroradiologists read the images twice independently 1 year apart.
RESULTS: Interrater agreement was good (kappa = 0.64 and 0.66 for either reading). Test-retest reliability was high (kappa = 0.75 and 0.74 for either rater). The open-ring sign clearly distinguished demyelinating lesions from neoplasms and infections. For demyelination versus neoplasm or infection, the specificity of the reading by the first neuroradiologist was 93.8 (95% CI, 86 to 98), and that of the second was 84.4 (95% CI, 74 to 92). The likelihood ratio of demyelination versus neoplasm averaged 5.2, and versus infection, 17.2. That is, if the lesions had the same incidence in the population, in the presence of an open-ring sign demyelination would be five times more likely than neoplasm and 17 times more likely than infection. However, given the much higher incidence of neoplasms and infections, these lesions are still frequently responsible for open-ring enhancement.
CONCLUSIONS: The open-ring sign is often present in large, contrast-enhancing demyelinating lesions and helps to differentiate them from neoplasms and infections.

Entities:  

Mesh:

Year:  2000        PMID: 10751251     DOI: 10.1212/wnl.54.7.1427

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  44 in total

1.  Differentiation of tumefactive demyelinating lesions from high-grade gliomas with the use of diffusion tensor imaging.

Authors:  C H Toh; K-C Wei; S-H Ng; Y-L Wan; M Castillo; C-P Lin
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

2.  Reproducibility of image interpretation in MRI of the prostate: application of the sextant framework by two different radiologists.

Authors:  Ullrich Mueller-Lisse; Ulrike Mueller-Lisse; Juergen Scheidler; Gerhardt Klein; Maximilian Reiser
Journal:  Eur Radiol       Date:  2005-04-20       Impact factor: 5.315

Review 3.  Imaging of multiple sclerosis: role in neurotherapeutics.

Authors:  Rohit Bakshi; Alireza Minagar; Zeenat Jaisani; Jerry S Wolinsky
Journal:  NeuroRx       Date:  2005-04

4.  Case 11: a young woman with ring-enhancing brain lesions.

Authors:  Irene Cortese; Avindra Nath
Journal:  MedGenMed       Date:  2006-01-05

Review 5.  MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findings.

Authors:  A Seewann; C Enzinger; M Filippi; F Barkhof; A Rovira; A Gass; D Miller; X Montalban; A Thompson; T Yousry; M Tintore; N de Stefano; J Palace; M Rovaris; C Polman; F Fazekas
Journal:  J Neurol       Date:  2007-11-15       Impact factor: 4.849

Review 6.  Brain metastases: neuroimaging.

Authors:  Whitney B Pope
Journal:  Handb Clin Neurol       Date:  2018

Review 7.  Tumefactive demyelinating lesions: nine cases and a review of the literature.

Authors:  Lei Xia; Song Lin; Zhong-cheng Wang; Shao-wu Li; Li Xu; Jing Wu; Shu-yu Hao; Chuan-chuan Gao
Journal:  Neurosurg Rev       Date:  2009-01-27       Impact factor: 3.042

Review 8.  The pathological spectrum of CNS inflammatory demyelinating diseases.

Authors:  Wei Hu; Claudia F Lucchinetti
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

Review 9.  Schilder's disease: non-invasive diagnosis? :A case report and review.

Authors:  Susanna Bacigaluppi; Gabriele Polonara; Mario L Zavanone; Rolando Campanella; Vincenzo Branca; Sergio M Gaini; Giovanni Tredici; Antonella Costa
Journal:  Neurol Sci       Date:  2009-07-17       Impact factor: 3.307

10.  Management of acute exacerbations in multiple sclerosis.

Authors:  Daniel Ontaneda; Alex D Rae-Grant
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.